Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.41M 1.31M 1.21M 2.27M 157M 2.3M 15.51M 6.07M 78.64M 6.16M 6.03M 260M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 6.97M 6.51M 5.97M 11.23M 777M 11.42M 76.83M 30.08M 390M 30.52M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+4.46%+4.92%+82.07%+134.31% 1,093B
+0.85%+4.81%+53.77%+58.51% 653B
+2.72%+6.92%+28.99%+77.15% 458B
+1.80%+0.52%+41.20%+44.05% 355B
+1.24%+2.35%+25.99%+42.21% 294B
+2.07%+2.97%+2.27%+13.06% 248B
+4.02%+6.29%+49.67%+68.96% 230B
+1.05%-0.02%-13.96%-52.13% 203B
+2.90%+8.63%+25.11%+94.52% 178B
Average -8.22%+3.13%+32.79%+53.40% 412.27B
Weighted average by Cap. +1.53%+3.65%+46.87%+73.74%

Financials

2007 2008
Net sales 23.47M 20.13M 18.8M 17.25M 32.43M 2.24B 32.96M 222M 86.85M 1.12B 88.11M 86.19M 3.72B 25.96M 22.27M 20.79M 19.08M 35.87M 2.48B 36.47M 245M 96.08M 1.24B 97.47M 95.35M 4.11B
Net income -20.86M -17.89M -16.71M -15.33M -28.82M -1.99B -29.3M -197M -77.2M -1B -78.32M -76.61M -3.31B -4.01M -3.44M -3.21M -2.94M -5.54M -383M -5.63M -37.86M -14.83M -192M -15.04M -14.71M -635M
Net Debt 18.79M 16.12M 15.05M 13.81M 25.97M 1.8B 26.39M 178M 69.54M 901M 70.55M 69.02M 2.98B 6.49M 5.57M 5.2M 4.77M 8.97M 620M 9.11M 61.33M 24.01M 311M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-